Sign up to save your podcasts
Or
Share Amicus Therapeutics CEO John Crowley
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Amicus Therapeutics CEO John Crowley
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Goldman Sachs
4.3
8686 ratings
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Talks at GS
View all
Exchanges
977 Listeners
Bloomberg Intelligence
406 Listeners
Masters in Business
2,175 Listeners
Odd Lots
1,993 Listeners
Invest Like the Best with Patrick O'Shaughnessy
2,342 Listeners
The Meb Faber Show - Better Investing
943 Listeners
Capital Allocators – Inside the Institutional Investment Industry
797 Listeners
The David Rubenstein Show
167 Listeners
UBS On-Air: Market Moves
191 Listeners
Making Sense
71 Listeners
Value Investing with Legends
208 Listeners
Thoughts on the Market
1,320 Listeners
At Any Rate
80 Listeners
The Memo by Howard Marks
435 Listeners
The Markets
80 Listeners